MedSwitcher
Head-to-Head Comparison

Wegovy Pill vs Wegovy Injection: Same Drug, Different Form

Same molecule, same company, radically different experience. Since December 2025, Wegovy is available as both a daily pill and a weekly injection. The pill eliminates needles and costs a fraction of the price — but it comes with a strict fasting requirement and uses a 50mg dose to compensate for ~1% oral bioavailability. Here's what you need to know to choose between them.

Updated April 20268 min readBased on clinical trial data
Quick Comparison
CategoryWegovy PillWegovy Injection
FormDaily pill (30-min fasting required)Weekly injection (subcutaneous)
Weight Loss (completers)16.6% (OASIS-1, 50mg, 68 wk)~17% (STEP-1, 2.4mg, 68 wk)
Weight Loss (ITT)15.1% (OASIS-1)~14.9% (STEP-1)
Self-Pay Cost$149–299/mo~$1,349/mo
Needle RequiredNoYes (auto-injector pen)
Food Restrictions30-min fast, ≤4 oz waterNone
Dosing FrequencyOnce dailyOnce weekly
Cold StorageNoYes (before first use)
Oral Bioavailability~1% (SNAC-enhanced)N/A — bypasses GI tract
CV Outcomes DataNone (extrapolated from injection)SELECT trial: 20% MACE reduction
FDA ApprovalDecember 2025June 2021
Wegovy Pill advantage Wegovy Injection advantage Tie

Choose your next step

Build a personalized switch plan first, or jump to treatment options if you already know which medication you want to discuss with a prescriber.

Get comparison and pricing alerts by email

Calculate Your Switch Plan

Get a personalized dose mapping, cost comparison, and timeline

Open the Calculator →

Efficacy: Remarkably Similar Results

The big surprise: the pill matches the injection.

Despite oral semaglutide having only ~1% bioavailability (compared to nearly 100% for the injection), Novo Nordisk compensated by using a much larger dose — 50mg daily for the pill vs 2.4mg weekly for the injection.

Head-to-head results:

  • Wegovy Pill (OASIS-1, 50mg): 15.1% weight loss (ITT) / 16.6% (completers) over 68 weeks
  • Wegovy Injection (STEP-1, 2.4mg): 14.9% weight loss (ITT) / ~17% (completers) over 68 weeks

These results are statistically comparable. The pill achieves essentially the same weight loss as the injection. This is a landmark achievement in drug delivery — getting a peptide to work orally at the same efficacy as an injection.

Important caveat: These are cross-trial comparisons (OASIS-1 vs STEP-1), not a direct head-to-head study. Patient populations differed slightly. However, the results are close enough that most experts consider them equivalent.

Convenience: Different Trade-offs

Neither form is universally more convenient — it depends on your lifestyle:

Wegovy Pill pros:

  • No needles — no injection anxiety, no sharps disposal
  • No cold storage — easier to travel with
  • No visible injection device

Wegovy Pill cons:

  • Must be taken on an empty stomach every morning
  • Only ≤4 oz of plain water to swallow
  • 30-minute wait before eating, drinking, or other medications
  • Daily commitment vs weekly injection

Wegovy Injection pros:

  • Once weekly — only 52 doses per year vs 365
  • No food restrictions at all
  • Can inject any time of day
  • Less daily mental load

Wegovy Injection cons:

  • Requires injection (needle, albeit a small auto-injector)
  • Needs refrigeration before first use
  • Sharps disposal required
  • Injection site reactions (~6% in STEP trials)

Bottom line: If you dislike needles and don't mind the fasting routine, choose the pill. If you'd rather deal with one weekly injection than a daily fasting requirement, choose the injection. Both have valid trade-offs.

Cost: The Pill Is a Game-Changer

This is the pill's biggest advantage:

  • Wegovy Pill: $149/mo (1.5mg, 4mg doses) to $299/mo (higher doses) self-pay
  • Wegovy Injection: ~$1,349/mo list price

That's a 77–89% cost reduction for the pill compared to the injection. For the ~16 million Americans without GLP-1 insurance coverage, this price difference is the deciding factor.

Why is the pill so much cheaper?

  • Pills are dramatically cheaper to manufacture than prefilled injection pens
  • No cold chain logistics required
  • Novo Nordisk priced it aggressively to compete with Foundayo ($149–349/mo)
  • Broader accessibility was a stated company goal

With savings cards: Both drop to ~$25/mo for eligible commercially insured patients, making the cost difference irrelevant for many insured patients.

The strategic implication: The pill's pricing effectively makes the injection's list price unsustainable for self-pay patients. Expect the injection to remain primarily an insurance-covered product.

Side Effects: Similar but Not Identical

Since both deliver the same molecule (semaglutide), the GI side effect profile is broadly similar:

Wegovy Pill (OASIS-1, 50mg):

  • Nausea: ~31%
  • Diarrhea: ~18%
  • Vomiting: ~21%
  • Constipation: ~14%

Wegovy Injection (STEP-1, 2.4mg):

  • Nausea: ~44%
  • Diarrhea: ~30%
  • Vomiting: ~24%
  • Constipation: ~24%
  • Injection site reactions: ~6%

Surprisingly, the pill appears to have lower GI side effect rates. This may be because oral semaglutide reaches target tissues through the portal circulation (via the gut), producing a different pharmacokinetic profile than subcutaneous injection. The pill also eliminates injection site reactions entirely.

Note: Cross-trial comparison limitations apply. These were different trials with different patient populations and different reporting standards.

Switching Between Pill and Injection

Many patients will consider switching forms — especially from injection to pill to save money.

Injection → Pill:

  • Start the pill the day after your last injection
  • Begin at the lowest pill dose and titrate up per your doctor's guidance
  • Expect similar efficacy once you reach the maintenance pill dose
  • There may be a brief period of reduced drug effect during the transition as the injection clears and the pill dose ramps up

Pill → Injection:

  • Less common but may be relevant if you can't maintain the fasting routine
  • Start the injection the day after your last pill
  • Your doctor may start at a lower injection dose to manage the switch

Key consideration: If you're on the injection and it's working well, the main reason to switch is cost. If your insurance covers the injection at $25/mo, there's no financial incentive to switch. If you're paying $1,349/mo out-of-pocket, the pill at $149–299/mo is a no-brainer.

The Bottom Line

Same molecule, very different experience. The Wegovy pill matches the injection on weight loss (15–17%) at a fraction of the cost ($149–299/mo vs $1,349/mo). Choose the pill if cost matters and you can handle daily fasting. Choose the injection if you prefer once-weekly dosing with no food restrictions, or if your insurance covers it. For new patients, the pill is likely the better starting point given its cost advantage.

Get GLP-1 Price Drop Alerts

Join 500+ patients tracking medication prices and availability

Get Free Alerts →

Compare Your Personalized Switch Plan

Switch Calculator
Enter your current medication details to get a personalized switch plan

Frequently Asked Questions

Is the Wegovy pill as effective as the injection?

Yes. In clinical trials, the Wegovy pill (50mg) produced 15.1–16.6% weight loss vs 14.9–17% for the injection over similar timeframes. Despite only ~1% of the oral dose being absorbed, the high 50mg dose compensates to achieve comparable efficacy.

Why is the Wegovy pill so much cheaper?

Pills are far cheaper to manufacture than prefilled injection pens. No cold chain storage or sharps disposal is needed. Novo Nordisk also priced the pill aggressively to compete with Eli Lilly's Foundayo ($149–349/mo).

Can I switch from the injection to the pill to save money?

Yes. Many patients and physicians are making this switch. Start the pill at the lowest dose the day after your last injection. You'll titrate up over several weeks. Discuss the transition plan with your prescriber to minimize any efficacy gap during the switch.

Does the Wegovy pill have the same heart benefits as the injection?

The SELECT cardiovascular outcomes trial used the injection, not the pill. No CV outcomes trial has been completed with oral semaglutide 50mg. While it's reasonable to expect some benefit from the same molecule, the pill's cardiovascular protection has not been independently confirmed.

Sources

  1. OASIS-1 Phase 3 Trial — oral semaglutide 50mg weight loss data
  2. STEP-1 Phase 3 Trial — semaglutide 2.4mg injection weight loss data
  3. SELECT Cardiovascular Outcomes Trial — semaglutide injection (NEJM, 2023)
  4. Novo Nordisk pricing announcements and Wegovy pill prescribing information, 2025–2026
Wegovy Injection trust snapshot
Medication
Wegovy
Tracked facts
10
Human verified
0
Last refreshed: 2026-04-07

This page pulls from MedSwitcher's structured medication fact database. Facts are tracked separately from page copy so we can update sources, pricing, and trial details without guessing.

Primary source trail
  • Wegovy Prescribing Information
  • STEP 1 trial
  • Wegovy list price

Want the boring but important details? Read our editorial policy and methodology.

Don't miss price changes

GLP-1 prices are changing — stay ahead

Foundayo prices may increase — get alerts before they do. Track price drops, shortages, and new switching guidance without checking back manually.

  • Price increase warnings before they hit
  • Savings card and coupon alerts
  • New switching guidance and availability updates

No spam. Unsubscribe anytime. We never share your email.

Related

This comparison is for informational purposes only and does not constitute medical advice. Clinical trial results referenced here come from different studies with different designs and patient populations — direct comparison between trials has inherent limitations. Always consult your healthcare provider.